TY  - RPRT
TI  - In silico transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing loss
AU  - Salehi, P.
AU  - Zallocchi, M.
AU  - Vijayakumar, S.
AU  - Urbanek, M.
AU  - Giffen, K. P.
AU  - Li, Y.
AU  - Hati, S.
AU  - Zuo, J.
PY  - 2022
DO  - 10.1101/2022.01.26.477836
UR  - https://www.biorxiv.org/content/10.1101/2022.01.26.477836v1
ID  - 10.1101/2022.01.26.477836
ER  -